CoChat
Sign Up
Cited by 65

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

miRNA-5119 regulates immune checkpoints in dendritic cells to enhance breast cancer immunotherapy

Zhang, Meng, Shi, Yanmei, Zhang, Yujuan, Wang, Yifan, Alotaibi, Faizah, Qiu, Li, Wang, Hongmei, Peng, Shanshan, Liu, Yanling, Li, Qing, Gao, Dian, Wang, Zhigang, Yuan, Keng, Dou, Fang-fang, Koropatnick, James, Xiong, Jianping, Min, Weiping·2020·Cancer Immunology, Immunotherapy
DOI 10.1007/s00262-020-02507-w
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00262-020-02507-w

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 49

  1. Jiang Y, Li Y, Zhu B (2015) T-cell exhaustion in the tumor microenvironment. Cell Death Dis 6:e1792. https://doi.org/10.1038/cddis.2015.162 · DOI
  2. Banerjee H, Kane LP (2018) Immune regulation by Tim-3. F1000Research 7:316. https://doi.org/10.12688/f1000research.13446.1 · DOI
  3. Grabmeier-Pfistershammer K, Stecher C, Zettl M, Rosskopf S, Rieger A, Zlabinger GJ, Steinberger P (2017) Antibodies targeting BTLA or TIM-3 enhance HIV-1 specific T cell responses in combination with PD-1 blockade. Clin Immunol 183:167–173. https://doi.org/10.1016/j.clim.2017.09.002 · DOI
  4. Mohammadizad H, Shahbazi M, Hasanjani Roushan MR, Soltanzadeh-Yamchi M, Mohammadnia-Afrouzi M (2019) TIM-3 as a marker of exhaustion in CD8(+) T cells of active chronic hepatitis B patients. Microb Pathog 128:323–328. https://doi.org/10.1016/j.micpath.2019.01.026 · DOI
  5. Moskophidis D, Lechner F, Pircher H, Zinkernagel RM (1993) Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362:758–761. https://doi.org/10.1038/362758a0 · DOI
  6. Mognol GP, Spreafico R, Wong V, Scott-Browne JP, Togher S, Hoffmann A, Hogan PG, Rao A, Trifari S (2017) Exhaustion-associated regulatory regions in CD8(+) tumor-infiltrating T cells. Proc Natl Acad Sci USA 114:E2776–E2785. https://doi.org/10.1073/pnas.1620498114 · DOI
  7. Goncalves Silva I, Yasinska IM, Sakhnevych SS et al (2017) The Tim-3-galectin-9 secretory pathway is involved in the immune escape of human acute myeloid leukemia cells. EBioMedicine 22:44–57. https://doi.org/10.1016/j.ebiom.2017.07.018 · DOI
  8. Kamata T, Suzuki A, Mise N et al (2016) Blockade of programmed death-1/programmed death ligand pathway enhances the antitumor immunity of human invariant natural killer T cells. Cancer Immunol Immunother CII 65:1477–1489. https://doi.org/10.1007/s00262-016-1901-y · DOI
  9. Cintolo JA, Datta J, Mathew SJ, Czerniecki BJ (2012) Dendritic cell-based vaccines: barriers and opportunities. Future Oncol 8:1273–1299. https://doi.org/10.2217/fon.12.125 · DOI
  10. Garg AD, Vara Perez M, Schaaf M, Agostinis P, Zitvogel L, Kroemer G, Galluzzi L (2017) Trial watch: dendritic cell-based anticancer immunotherapy. Oncoimmunology 6:e1328341. https://doi.org/10.1080/2162402X.2017.1328341 · DOI
  11. Jones A, Bourque J, Kuehm L, Opejin A, Teague RM, Gross C, Hawiger D (2016) Immunomodulatory functions of BTLA and HVEM govern induction of extrathymic regulatory T cells and tolerance by dendritic cells. Immunity 45:1066–1077. https://doi.org/10.1016/j.immuni.2016.10.008 · DOI
  12. Leskela S, Serrano A, de la Fuente H, Rodriguez-Munoz A, Ramos-Levi A, Sampedro-Nunez M, Sanchez-Madrid F, Gonzalez-Amaro R, Marazuela M (2015) Graves' disease is associated with a defective expression of the immune regulatory molecule galectin-9 in antigen-presenting dendritic cells. PLoS ONE 10:e0123938. https://doi.org/10.1371/journal.pone.0123938 · DOI
  13. Zhang Y, Fu J, Shi Y et al (2018) A new cancer immunotherapy via simultaneous DC-mobilization and DC-targeted IDO gene silencing using an immune-stimulatory nanosystem. Int J Cancer 143:2039–2052. https://doi.org/10.1002/ijc.31588 · DOI
  14. Carrington JC, Ambros V (2003) Role of microRNAs in plant and animal development. Science 301:336–338. https://doi.org/10.1126/science.1085242 · DOI
  15. Pfeffer S, Zavolan M, Grasser FA et al (2004) Identification of virus-encoded microRNAs. Science 304:734–736. https://doi.org/10.1126/science.1096781 · DOI
  16. Naseri Z, Oskuee RK, Jaafari MR, Forouzandeh Moghadam M (2018) Exosome-mediated delivery of functionally active miRNA-142-3p inhibitor reduces tumorigenicity of breast cancer in vitro and in vivo. Int J Nanomed 13:7727–7747. https://doi.org/10.2147/IJN.S182384 · DOI
  17. Pichiorri F, Palmieri D, De Luca L et al (2013) In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation. J Exp Med 210:951–968. https://doi.org/10.1084/jem.20120950 · DOI
  18. Banerjee N, Talcott S, Safe S, Mertens-Talcott SU (2012) Cytotoxicity of pomegranate polyphenolics in breast cancer cells in vitro and vivo: potential role of miRNA-27a and miRNA-155 in cell survival and inflammation. Breast Cancer Res Treat 136:21–34. https://doi.org/10.1007/s10549-012-2224-0 · DOI
  19. Deng YW, Hao WJ, Li YW, Li YX, Zhao BC, Lu D (2018) Hsa-miRNA-143-3p reverses multidrug resistance of triple-negative breast cancer by inhibiting the expression of its target protein cytokine-induced apoptosis inhibitor 1 in vivo. J Breast Cancer 21:251–258. https://doi.org/10.4048/jbc.2018.21.e40 · DOI
  20. Ji Y, Han Z, Shao L, Zhao Y (2016) Evaluation of in vivo antitumor effects of low-frequency ultrasound-mediated miRNA-133a microbubble delivery in breast cancer. Cancer Med 5:2534–2543. https://doi.org/10.1002/cam4.840 · DOI
  21. Liu C, Wang S, Zhu S, Wang H, Gu J, Gui Z, Jing J, Hou X, Shao Y (2016) MAP3K1-targeting therapeutic artificial miRNA suppresses the growth and invasion of breast cancer in vivo and in vitro. SpringerPlus 5:11. https://doi.org/10.1186/s40064-015-1597-z · DOI
  22. Yang J, Liu R, Deng Y, Qian J, Lu Z, Wang Y, Zhang D, Luo F, Chu Y (2017) MiR-15a/16 deficiency enhances anti-tumor immunity of glioma-infiltrating CD8+ T cells through targeting mTOR. Int J Cancer 141:2082–2092. https://doi.org/10.1002/ijc.30912 · DOI
  23. Yang X, Zhao C, Bamunuarachchi G et al (2019) miR-193b represses influenza A virus infection by inhibiting Wnt/beta-catenin signalling. Cell Microbiol 21:e13001. https://doi.org/10.1111/cmi.13001 · DOI
  24. Li Q, Johnston N, Zheng X, Wang H, Zhang X, Gao D, Min W (2016) miR-28 modulates exhaustive differentiation of T cells through silencing programmed cell death-1 and regulating cytokine secretion. Oncotarget 7:53735–53750. https://doi.org/10.18632/oncotarget.10731 · DOI
  25. Palucka K, Banchereau J (2013) Dendritic-cell-based therapeutic cancer vaccines. Immunity 39:38–48. https://doi.org/10.1016/j.immuni.2013.07.004 · DOI · Paper page
  26. Pusztai L, Karn T, Safonov A, Abu-Khalaf MM, Bianchini G (2016) New strategies in breast cancer: immunotherapy. Clin Cancer Res 22:2105–2110. https://doi.org/10.1158/1078-0432.CCR-15-1315 · DOI
  27. Topalian SL, Drake CG, Pardoll DM (2015) Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell 27:450–461. https://doi.org/10.1016/j.ccell.2015.03.001 · DOI · Paper page
  28. Vasaturo A, Verdoes M, de Vries J, Torensma R, Figdor CG (2015) Restoring immunosurveillance by dendritic cell vaccines and manipulation of the tumor microenvironment. Immunobiology 220:243–248. https://doi.org/10.1016/j.imbio.2014.11.007 · DOI
  29. Goh JN, Loo SY, Datta A et al (2016) microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer. Biol Rev 91:409–428. https://doi.org/10.1111/brv.12176 · DOI
  30. Wang Q, Lin W, Tang X, Li S, Guo L, Lin Y, Kwok HF (2017) The roles of microRNAs in regulating the expression of PD-1/PD-L1 immune checkpoint. Int J Mol Sci. https://doi.org/10.3390/ijms18122540 · DOI
  31. Holla S, Stephen-Victor E, Prakhar P, Sharma M, Saha C, Udupa V, Kaveri SV, Bayry J, Balaji KN (2016) Mycobacteria-responsive sonic hedgehog signaling mediates programmed death-ligand 1- and prostaglandin E2-induced regulatory T cell expansion. Sci Rep 6:24193. https://doi.org/10.1038/srep24193 · DOI
  32. Jin C, Cheng L, Hoxtermann S, Xie T, Lu X, Wu H, Skaletz-Rorowski A, Brockmeyer NH, Wu N (2017) MicroRNA-155 is a biomarker of T-cell activation and immune dysfunction in HIV-1-infected patients. HIV Med 18:354–362. https://doi.org/10.1111/hiv.12470 · DOI
  33. Mohnle P, Hirschberger S, Hinske LC et al (2018) MicroRNAs 143 and 150 in whole blood enable detection of T-cell immunoparalysis in sepsis. Mol Med 24:54. https://doi.org/10.1186/s10020-018-0056-z · DOI
  34. Moffett HF, Cartwright ANR, Kim HJ et al (2017) The microRNA miR-31 inhibits CD8(+) T cell function in chronic viral infection. Nat Immunol 18:791–799. https://doi.org/10.1038/ni.3755 · DOI
  35. Wang Y, Zhang Z, Ji D et al (2015) Regulation of T cell function by microRNA-720. Sci Rep 5:12159. https://doi.org/10.1038/srep12159 · DOI
  36. Cui J, Li Q, Luo M et al (2018) Leukemia cell-derived microvesicles induce T cell exhaustion via miRNA delivery. Oncoimmunology 7:e1448330. https://doi.org/10.1080/2162402X.2018.1448330 · DOI
  37. Sun C, Lan P, Han Q et al (2018) Oncofetal gene SALL4 reactivation by hepatitis B virus counteracts miR-200c in PD-L1-induced T cell exhaustion. Nat Commun 9:1241. https://doi.org/10.1038/s41467-018-03584-3 · DOI
  38. Haymaker C, Wu R, Bernatchez C, Radvanyi L (2012) PD-1 and BTLA and CD8(+) T-cell "exhaustion" in cancer: "Exercising" an alternative viewpoint. Oncoimmunology 1:735–738. https://doi.org/10.4161/onci.20823 · DOI
  39. Ohaegbulam KC, Liu W, Jeon H, Almo SC, Zang X (2017) Tumor-expressed immune checkpoint B7x promotes cancer progression and antigen-specific CD8 T cell exhaustion and suppressive innate immune cells. Oncotarget 8:82740–82753. https://doi.org/10.18632/oncotarget.21098 · DOI
  40. Zhang Y, Cai P, Li L et al (2017) Co-expression of TIM-3 and CEACAM1 promotes T cell exhaustion in colorectal cancer patients. Int Immunopharmacol 43:210–218. https://doi.org/10.1016/j.intimp.2016.12.024 · DOI
  41. Zhou H, Liu T, Wang Z (2017) Analysis of non-small cell lung cancer microenvironment indicates preponderance of T cell exhaustion marker expression. Exp Cell Res 360:205–209. https://doi.org/10.1016/j.yexcr.2017.09.008 · DOI
  42. Hu CY, Zhang YH, Wang T, Chen L, Gong ZH, Wan YS, Li QJ, Li YS, Zhu B (2016) Interleukin-2 reverses CD8(+) T cell exhaustion in clinical malignant pleural effusion of lung cancer. Clin Exp Immunol 186:106–114. https://doi.org/10.1111/cei.12845 · DOI
  43. Sabzevary-Ghahfarokhi M, Shirzad H, Rafieian-Kopaei M, Ghatreh-Samani M, Shohan M (2018) The role of inflammatory cytokines in creating T cell exhaustion in cancer. Cancer Biother Radiopharm 33:267–273. https://doi.org/10.1089/cbr.2018.2449 · DOI
  44. Peng Y (2017) Forced expression of IL-7R promotes CD8 T cell cytotoxicity to self antigen. PLoS ONE 12:e0188112. https://doi.org/10.1371/journal.pone.0188112 · DOI
  45. Ye B, Liu X, Li X, Kong H, Tian L, Chen Y (2015) T-cell exhaustion in chronic hepatitis B infection: current knowledge and clinical significance. Cell Death Dis 6:e1694. https://doi.org/10.1038/cddis.2015.42 · DOI
  46. Derre L, Rivals JP, Jandus C, Pastor S, Rimoldi D, Romero P, Michielin O, Olive D, Speiser DE (2010) BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination. J Clin Investig 120:157–167. https://doi.org/10.1172/JCI40070 · DOI · Paper page
  47. Matsuzaki J, Gnjatic S, Mhawech-Fauceglia P et al (2010) Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer. Proc Natl Acad Sci USA 107:7875–7880. https://doi.org/10.1073/pnas.1003345107 · DOI · Paper page
  48. Huang Y, Zhao Y, Ran X, Wang C (2014) Increased expression of herpesvirus entry mediator in 1,25-dihydroxyvitamin D3-treated mouse bone marrow-derived dendritic cells promotes the generation of CD4(+)CD25(+)Foxp3(+) regulatory T cells. Mol Med Rep 9:813–818. https://doi.org/10.3892/mmr.2013.1874 · DOI
  49. Liu Y, Zhang Y, Zheng X et al (2016) Gene silencing of indoleamine 2,3-dioxygenase 2 in melanoma cells induces apoptosis through the suppression of NAD+ and inhibits in vivo tumor growth. Oncotarget 7:32329–32340. https://doi.org/10.18632/oncotarget.8617 · DOI

Cited by

Sorted by citations

See all 65

Metadata

Authors
Zhang, M., Shi, Y., Zhang, Y., Wang, Y., Alotaibi, F., Qiu, L., Wang, H., Peng, S., Liu, Y., Li, Q., Gao, D., Wang, Z., Yuan, K., Dou, F.-F., Koropatnick, J., Xiong, J., & Min, W.
Venue
Cancer Immunology, Immunotherapy
Publisher
Springer Science and Business Media LLC
Published
2020-02-20
Volume
69
Issue
6
Pages
951-967
ISSN
  • 0340-7004
  • 1432-0851
DOI
10.1007/s00262-020-02507-w
Cited by
65
References
6
Language
en
Licence
Funders
  • National Natural Science Foundation of China (81673009, 81803064, 81660274)
  • Natural Science Foundation of Jiangxi (20192ACB21027, 20192ACBL20021, 20143ACG70020)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: miRNA-5119 regulates immune checkpoints in dendritic cells to enhance breast cancer immunotherapy. https://app.cochat.ai/papers/10.1007/s00262-020-02507-w
The paper
Zhang, M., Shi, Y., Zhang, Y., Wang, Y., Alotaibi, F., Qiu, L., Wang, H., Peng, S., Liu, Y., Li, Q., Gao, D., Wang, Z., Yuan, K., Dou, F.-F., Koropatnick, J., Xiong, J., & Min, W. (2020). miRNA-5119 regulates immune checkpoints in dendritic cells to enhance breast cancer immunotherapy. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-020-02507-w